Immunoglobulin therapy, myocardial diseases and atherosclerosis: Recent experimental and clinical studies

Current Cardiology Reviews

Volumn 3, Issue 1, 2007, Pages 15-21

  Kishimoto, Chiharu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Heart failure; Immunoglobulin; Myocarditis

Indexed keywords

APOLIPOPROTEIN E; FC RECEPTOR; IMMUNOGLOBULIN;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; ENTEROVIRUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOMODULATION; MYOCARDIAL DISEASE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 33847253835     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340307779940013     Document Type: Review

References (29)

1. Clarkson SB, Bussel JB, Kimberly RP, Valinsky JE, Nachman RL, Unkeless JC. Treatment of refractory immune thombocytopenic purpura with an anti-Fc-receptor antibody. N Engl J Med 1986; 314: 1236-9.
2. Lam L, Whitsett CF, McNicholl JM, Hodge TW, Hooper J. Immunologically active proteins in intravenous immunoglobulin. Lancet 1993; 342: 678.
3. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-55.
4. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91: 602-7.
5. Rich RR. Intravenous IgG: supertherapy for superantigens? J Clin Invest 1993; 91: 378.
6. Drucker NA, Colan SD, Lewis AB, et al. γ-globulin treatment of acute myocarditis in the pediatricpopulation. Circulation 1994; 89: 252-7.
7. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-7.
8. Jayne DR, Davies MJ, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337: 1137-9.
9. Debré M, Bonnet MC, Fridman WH, et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993; 342: 945-9.
10. Samuelsson A, Towers TL, Ravetch TV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fe receptor. Science 2001; 291: 484-6.
11. Kishimoto C, Hiraoka Y, Takamatsu N, Takada H, Kamiya H, Ochiai H. An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency (SCID) mouse. Cardiovasc Res 2003; 60: 397-403.
12. Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Circulation 1995; 92: 1604-11.
13. Kishimoto C. Intravenous IgG: Supertherapy for myocarditis and acute dilated cardiomopathy. Circulation 1999; 99: 975-6.
14. Kishimoto C, Takamatsu N, Kawamata H, Shinohara H, Ochiai H. Immunoglobulin treatment ameliorates murine myocarditis associates with reduction of neurohumoral activity and improvement of extracellular matrix change. J Am Coll Cardiol 2000; 36: 1979-84.
15. Kishimoto C, Hiraoka Y, Takada H. Effects of immunoglobulin upon murine myocarditis caused by influenza A virus. Superiority of intact type to F(ab') type. J Cardiovasc Pharmacol 2004; 43: 61-7.
16. Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 1992; 85: 1918-1926.
17. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630-3636.
18. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991; 147: 2141-2147.
19. Shioji K, Kishimoto C, Sasayama S: Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis. Concomitant suppression of the expression of dendritic cells. Circ Res 2001; 89: 540-546.
20. Shioji K, Kishimoto C, Nakamura H, et al. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett 2000; 472: 109-13.
21. Shioji K, Yuan Z, Kita T, Kishimoto C. Immunoglobulin treatment suppressed adoptively transferred autoimmune myocarditis in severe combined immunodeficient mice. Am J Physiol Heart Circ Physiol 2004; 287: H2619-25.
22. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure. An overview. Heart 2004; 90: 464-70.
23. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005; 95 (11A): 3C-8C, 38C-40C.
24. Kishimoto C, Takada H, Kawamata H, Umetake M, Ochiai H. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis by the reduction of inflammatory cytokines. J Pharmacol Exp Ther 2001; 299: 645-51.
25. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
26. Yuan Z, Kishimoto C, Sano H, Shioji K, Xu Y, Yokode M. Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. Am J Physiol 2003; 285: H899-906.
27. Kishimoto C, Shioji K, Kinoshita M, et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91: 173-8.
28. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103: 2254-9.
29. Shioji K, Matsuura Y, Iwase T, et al. Successful immunoglobulin treatment for fulminant myocarditis with analysis of serum thioredoxin (TRX). A case report. Circ J 2002; 66: 977-80.